{"schema_version":"secwatch.filing_event.v1","accession":"0001171843-26-005078","form_type":"8-K","ticker":"ALHC","cik":"0001832466","company_name":"Alignment Healthcare, Inc.","filed_at":"2026-07-30T20:01:17+00:00","discovered_at":"2026-07-30T20:02:00.492079+00:00","generated_at":"2026-07-30T20:02:08.948357+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"positive","materiality_score":0.8,"calibrated_materiality_score":0.8,"confidence":"high","headline":"Alignment Healthcare Q2 revenue $1.34B (+31.6% YoY); raises full-year guidance","bullets":["Total revenue $1,335.6M, up 31.6% YoY; Medicare Advantage membership 294,100 (+31.5% YoY).","Adjusted gross profit $182.9M (+35.3% YoY); medical benefits ratio 86.3%, improved 40 bps.","Adjusted EBITDA $68.1M (5.1% margin), up 48.4% YoY; net income $36.6M vs $15.7M prior year.","Company raised midpoint of all full-year guidance metrics: membership, revenue, adjusted gross profit, and adjusted EBITDA.","CEO John Kao cited strength of clinical model and AI-enabled capabilities driving results."],"urls":{"canonical":"https://secwatch.observer/filing/0001171843-26-005078","json":"https://secwatch.observer/filing/0001171843-26-005078.json","markdown":"https://secwatch.observer/filing/0001171843-26-005078.md","text":"https://secwatch.observer/filing/0001171843-26-005078.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1832466/000117184326005078/0001171843-26-005078-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1832466/000117184326005078/f8k_073026.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-07-30T20:02:08.948357+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}